drugset / Trial / NCT00198510

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

NCT00198510 ↗

Phase 3 Completed 750 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if intravitreal injection of Vitrase (ovine hyaluronidase) clears vitreous hemorrhage

Timeline

Start
1998-11
Primary completion
2001-09
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic 7.5 iu Intravitreal
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic 55 iu Intravitreal
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic 75 iu Intravitreal

Indications